Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Renee L. Hajnik(The University of Texas Medical Branch at Galveston), Haitao Hu(Zhejiang Normal University), Jessica A. Plante(The University of Texas Medical Branch at Galveston), Jie Sun(Mayo Clinic), Scott C. Weaver(Bipar), Lynn Soong(The University of Texas Medical Branch at Galveston), Awadalkareem Adam(The University of Texas Medical Branch at Galveston), Dionna Scharton(The University of Texas Medical Branch at Galveston), Jiaren Sun(The University of Texas Medical Branch at Galveston), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), David H. Walker(The University of Texas Medical Branch at Galveston), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Yuejin Liang(The University of Texas Medical Branch at Galveston), Chaojie Zhong(The University of Texas Medical Branch at Galveston), Nicholas C. Hazell(The University of Texas Medical Branch at Galveston), Tian Wang(The University of Texas Medical Branch at Galveston), Srinivasa Reddy Bonam(Centre National de la Recherche Scientifique), Jinyi Tang(Carter Center), Yang Liu(The University of Texas Medical Branch at Galveston), Grace Rafael(The University of Texas Medical Branch at Galveston), Kenneth S. Plante(The University of Texas Medical Branch at Galveston)
Cited by 129
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Scientists’ warning to humanity: microorganisms and climate change
|Nature Reviews Microbiology|2019|2.1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751